Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage

Clinical trial NCT01893190 · COMPLETED

Trial details

NCT number: NCT01893190
Sponsor: Edge Therapeutics Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ruptured Cerebral Aneurysm Ruptured Berry Aneurysm

Start date: 2013-09-01
Primary completion: 2016-01-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.